Compare PCVX & SLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCVX | SLM |
|---|---|---|
| Founded | 2013 | 1972 |
| Country | United States | United States |
| Employees | N/A | 1788 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 3.8B |
| IPO Year | 2020 | N/A |
| Metric | PCVX | SLM |
|---|---|---|
| Price | $54.00 | $19.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $98.33 | $32.45 |
| AVG Volume (30 Days) | 1.0M | ★ 4.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.17 |
| Revenue Next Year | N/A | $4.64 |
| P/E Ratio | ★ N/A | $6.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.09 | $17.77 |
| 52 Week High | $76.61 | $34.55 |
| Indicator | PCVX | SLM |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 36.03 |
| Support Level | $42.30 | $17.77 |
| Resistance Level | $57.50 | $28.57 |
| Average True Range (ATR) | 3.01 | 1.09 |
| MACD | -0.92 | 0.20 |
| Stochastic Oscillator | 0.00 | 51.08 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
SLM Corp is an education solutions company. Its business is to originate and service loans to students and their families to finance the cost of their education. The term' Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.